October 24, 2021
TheStreet home
TheStreet home
INVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search
Join Jim Cramer's Investing Club
Subscribe

Pharmaceuticals

Athira Pharma Lead
INVESTING

Athira Pharma Stock Climbs on Alzheimer's Test as CEO Resigns

Ocular Therapeutix Lead
INVESTING

Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint HOLD

Moderna vaccine Lead
INVESTING

FDA Clears 'Mix and Match' Covid-19 Booster Shots

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters
INVESTING

Pfizer, BioNTech Report 95.6% Efficacy for Covid Vaccine Booster

Ford Lead
INVESTING

5 Top Stock Gainers for Thursday: Ford, Pinterest, Pfizer

Novavax Lead
MARKETS

Novavax Stock Plunges On Report of COVID Vaccine Production Delays

Stock Market President's Day Lead
INVESTING

Stocks Finish Higher On Earnings Strength

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss
MARKETS

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

No More Tears for Johnson & Johnson?
MARKETS

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear
INVESTING

Adamis Pharma Stock Jumps as FDA Clears Opioid-Overdose Treatment

Johnson & Johnson's vaccine Lead
Video

Second Johnson & Johnson Shot? Here’s What the FDA Advisor Panel Said

Moderna Lead
INVESTING

FDA Panel Recommends Moderna COVID-19 Booster Shots

United Parcel Service
INVESTING

5 Top Stock Gainers for Thursday: UPS, PayPal, UnitedHealth

Acadia Healthcare Lead
INVESTING

Acadia Stock Falls on Morgan Stanley Downgrade, Price Target Cut

Regeneron, Sanofi Score Eczema Drug Approval
INVESTING

Regeneron Covid Antibody Treatment Accepted for FDA Review

Johnson & Johnson's vaccine Lead
INVESTING

FDA Staff Shows Cautious Optimism for J&J's Booster Shot

Vimeo Pulls the Plug on Empty Promises of Subscription Service
INVESTING

5 Top Stock Gainers for Wednesday: Plug Power, Workday, Vimeo

Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering
INVESTING

Crispr Stock Down on Data for CAR-T Therapy Candidate

Glaxo, IP and PetMed Poised to Go Higher
INVESTING

Glaxo Stock Higher on Reported Plan to Field PE Bids for Consumer Unit

SoFi Technologies Lead
INVESTING

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
Video

Everything We Know About Merck's Antiviral COVID Pill

Merck
MARKETS

Merck Applies For Emergency FDA Approval Of COVID Pill Treatment

ChemoCentryx Lead
INVESTING

ChemoCentryx Stock Leaps as FDA Approves Vasculitis Drug

Johnson & Johnson Latest to Pull Ads From YouTube
INVESTING

Johnson & Johson Asks FDA for Wider Use of Juvenile Arthritis Drug